Renal denervation for the management of hypertension. Joint position statement from the SEH-LELHA and the ACI-SEC
REC: interventional cardiology (English Edition) · 09.02.2022
DOI: 10.24875/recice.m21000235 ↗Kurz gefasst
Fachartikel in der Zeitschrift REC: interventional cardiology (English Edition), online erschienen am 09.02.2022. Verfasst von Oriol Rodríguez-Leor und 13 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Hypertension is the most prevalent cardiovascular risk factor. Despite pharmacological treatment, a high percentage of patients do not achieve an adequate blood pressure control. Renal sympathetic denervation is a minimally invasive intervention for the management of hypertension involving the interruption of the renal artery sympathetic nervous system using a catheter-based approach. The early studies showed promising results, but the controversial results coming from the SYMPLICITY HTN-3 trial sent this technique into oblivion. Over the last 3 years, new clinical trials have appeared including new devices used in different populations, which definitively proves the effectiveness of renal sympathetic denervation. This joint position statement from the Spanish Society of Hypertension-Spanish League for Combating High Blood Pressure (SEH-LELHA), and the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) reviews the evidence available on the efficacy and safety profile of renal sympathetic denervation for the management of hypertension. Based on the results of clinical trials, recommendations have been established on what patients may be eligible for renal sympathetic denervation and under what circumstances.
Zitieren
APA
Rodríguez-Leor, O., Jaén-Águila, F., Segura, J., Núñez-Gil, I. J., García-Touchard, A., Rubio, E., Troya, M., Diego-Mediavilla, J., Cequier, Á., Moreno, R., Martell, N., Beltrán, P., Molina, E., & García-Donaire, A. J. A. (2022). Renal denervation for the management of hypertension. Joint position statement from the SEH-LELHA and the ACI-SEC. REC: interventional cardiology (English Edition). https://doi.org/10.24875/recice.m21000235
Vancouver
Rodríguez-Leor O, Jaén-Águila F, Segura J, Núñez-Gil IJ, García-Touchard A, Rubio E, et al. Renal denervation for the management of hypertension. Joint position statement from the SEH-LELHA and the ACI-SEC. REC: interventional cardiology (English Edition). 2022. doi:10.24875/recice.m21000235
BibTeX
@article{RodrguezLeor2022,
author = {Rodríguez-Leor, Oriol and Jaén-Águila, Fernando and Segura, Julián and Núñez-Gil, Iván J. and García-Touchard, Arturo and Rubio, Esther and Troya, Maribel and Diego-Mediavilla, Juan and Cequier, Ángel and Moreno, Raúl and Martell, Nieves and Beltrán, Paola and Molina, Eduardo and García-Donaire, and José Antonio},
title = {Renal denervation for the management of hypertension. Joint position statement from the SEH-LELHA and the ACI-SEC},
journal = {REC: interventional cardiology (English Edition)},
year = {2022},
doi = {10.24875/recice.m21000235}
}
EUVIMED